RxDoctor Payments DataLook up a doctor →

Nicholas Benner, DO

Dermatology · Columbus, OHNPI 1316268618

Payments from drug & device makers

$356,231in general payments, 2019–2025

Across 1,425 payments — averaging $249.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$139K
  • Galderma Laboratories, L.p.$98K
  • Janssen Scientific Affairs, LLC$46K
  • AbbVie$36K
  • Novartis$13K
  • Sanofi$7K
  • plus $18K from 31 others

What the payments were for

  • Consulting fees$17,5435%
  • Speaking & faculty fees$288,92281%
  • Travel & lodging$15,1254%
  • Food & beverage$33,97710%
  • Education$6640%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$356,231 in reported general payments places this provider in the 90th percentile of 460 dermatology providers in Ohio.

See all dermatology providers in Ohio

Medicare billing

Part B allowed, 2024
$321,077
Medicare patients
1,216
Services billed
5,261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TremfyaGuselkumab48$640,990
Cosentyx Unoready PenSecukinumab47$451,499
Skyrizi PenRisankizumab-Rzaa21$430,112
Dupixent PenDupilumab74$280,412
Cosentyx Sensoready (2 Pens)Secukinumab12$89,361
Dupixent SyringeDupilumab13$48,067
Tacrolimus47$6,364
Fluorouracil63$5,013
Clobetasol Propionate142$4,999
Betamethasone Dipropionate92$4,238
Dutasteride106$3,576
Metronidazole73$2,976
Ketoconazole156$2,681
Desonide45$2,596
Calcipotriene14$1,955

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonTremfya$138,680$640,99048 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 460 dermatology providers in Ohio.

Other dermatology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →